Akari Therapeutics appoints Olga Anczukow to SAB

Akari Therapeutics (AKTX) announced the appointment of Olga Anczukow, Ph.D. to its Scientific Advisory Board. She currently serves as an Associate Professor at The Jackson Laboratory for Genomic Medicine and a Co-Program Leader at the NCI-designated Jackson Laboratory Cancer Center, and holds a joint faculty appointment at University of Connecticut School of Medicine, where she leads a multidisciplinary research program focused on elucidating the mechanisms by which alternative RNA splicing, a fundamental process in gene expression regulation, becomes misregulated in cancer and drives tumor initiation, progression, metastasis, and therapeutic resistance.